Heparin Therapy for Thromboembolic Disorders
- 16 September 1983
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 250 (11) , 1413-1416
- https://doi.org/10.1001/jama.1983.03340110027026
Abstract
One hundred thirty-four patients with venous thrombosis or pulmonary embolism, confirmed by radiological techniques, received continuous-pump heparin therapy while their responses were monitored by the activated coagulation time (ACT). The suggested protocol was as follows: (1) give an intravenous bolus of about 50 units/kg; (2) follow with 15 to 25 units/kg/hr; (3) modify infusion rate to maintain ACT of 150 to 190 s; (4) after two or three days with ACT in target range, start oral warfarin sodium therapy; (5) after three to five days of warfarin therapy, if prothrombin time is two to 2 1/2 times the control value, discontinue heparin administration. One hundred thirty-two patients responded, with no heparin failures. Dangerous bleeding occurred in two who received excessive amounts of heparin. Some patients, mostly with short ACTs, responded slowly; some, many with long ACTs, had minor bleeding. The protocol proved successful and safe when followed closely. (JAMA1983;250:1413-1416)Keywords
This publication has 6 references indexed in Scilit:
- Monitoring Response Of Disease To Heparin Therapy With The Activated Coagulation Time (ACT)Published by Georg Thieme Verlag KG ,1981
- Heparin therapy for deep venous thrombosisThe American Journal of Surgery, 1980
- Heparin therapy: A randomized prospective studyAmerican Heart Journal, 1979
- Bedside monitoring of heparin therapyThe American Journal of Surgery, 1978
- Progress Report: The Activated Coagulation Time of Whole Blood (ACT)American Journal of Clinical Pathology, 1976
- Monitoring heparin therapy in hemodialysis. A report on the activated whole blood coagulation time testsPublished by American Medical Association (AMA) ,1973